BBC3 and prostate carcinoma: Additionally, our CBZ-loaded NT and T NPs have shown effective apoptotic activity in PC3 prostate cancer cells via increased expression of PUMA and by activating and cleaving Caspase-3 (Supplementary Figure S4).